Methods for affecting body composition using amylin agonists
Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ROTH JONATHAN DAVID MACK CHRISTINE M |
| description | Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8748375B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8748375B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8748375B23</originalsourceid><addsrcrecordid>eNrjZLDxTS3JyE8pVkjLL1JITEtLTS7JzEtXSMpPqVRIzs8tyC_OLMnMz1MoLQYJJ-ZW5mTmKSSm5-dlFpcU8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSS-NBgC3MTC2NzUycjYyKUAAC_rjAl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods for affecting body composition using amylin agonists</title><source>esp@cenet</source><creator>ROTH JONATHAN DAVID ; MACK CHRISTINE M</creator><creatorcontrib>ROTH JONATHAN DAVID ; MACK CHRISTINE M</creatorcontrib><description>Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140610&DB=EPODOC&CC=US&NR=8748375B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140610&DB=EPODOC&CC=US&NR=8748375B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROTH JONATHAN DAVID</creatorcontrib><creatorcontrib>MACK CHRISTINE M</creatorcontrib><title>Methods for affecting body composition using amylin agonists</title><description>Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDxTS3JyE8pVkjLL1JITEtLTS7JzEtXSMpPqVRIzs8tyC_OLMnMz1MoLQYJJ-ZW5mTmKSSm5-dlFpcU8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSS-NBgC3MTC2NzUycjYyKUAAC_rjAl</recordid><startdate>20140610</startdate><enddate>20140610</enddate><creator>ROTH JONATHAN DAVID</creator><creator>MACK CHRISTINE M</creator><scope>EVB</scope></search><sort><creationdate>20140610</creationdate><title>Methods for affecting body composition using amylin agonists</title><author>ROTH JONATHAN DAVID ; MACK CHRISTINE M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8748375B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ROTH JONATHAN DAVID</creatorcontrib><creatorcontrib>MACK CHRISTINE M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROTH JONATHAN DAVID</au><au>MACK CHRISTINE M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods for affecting body composition using amylin agonists</title><date>2014-06-10</date><risdate>2014</risdate><abstract>Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US8748375B2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Methods for affecting body composition using amylin agonists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A25%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROTH%20JONATHAN%20DAVID&rft.date=2014-06-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8748375B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |